Stocks
Eli Lilly and CompanyLLY
NYSEHealthcarePharmaceuticals$985.08+0.80%
A global pharmaceutical manufacturer focused on developing and commercializing medicines for diabetes, obesity, oncology, immunology, and neuroscience. Its rapidly growing GLP-1 franchise, including treatments such as Mounjaro and Zepbound, has made the company a central player in the weight‑loss an...
Market Cap: $929.3B52W Range: $623.78 – $1133.95
Congressional Interest in Eli Lilly and Company (LLY)
1 member of Congress has disclosed 5 trades in Eli Lilly and Company (LLY), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
1
Buys
2
Sells
3
Who in Congress Is Trading LLY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2007-04-01 | MICHAEL T. MCCAUL | sell | $56,465.44 |
| 2007-04-01 | MICHAEL T. MCCAUL | sell | $56,465.44 |